STEREOTAXIS INC (STXS)
Health Care · Robotic-assisted interventional medical devices · NYSE American
Stereotaxis develops robotic magnetic navigation systems for minimally invasive interventional procedures in cardiology, electrophysiology, and vascular interventions.
What STEREOTAXIS INC does
Stereotaxis designs, manufactures, and markets robotic magnetic navigation systems that enable physicians to perform minimally invasive interventional procedures with greater precision and efficiency. The company's primary product is the Niobe robotic magnetic navigation system, which guides catheters and medical devices through the body using computer-controlled magnetic fields. The company generates revenue from systems sales, as well as from disposables, services, and accessories that support ongoing clinical use. Stereotaxis operates globally, with a focus on hospitals and interventional centers performing cardiac electrophysiology, cardiology, and vascular procedures.
Themes: Robotic minimally invasive surgery, Interventional cardiology, Cardiac electrophysiology, Medical device innovation, Catheter-based interventions, Precision guidance systems
Fundamentals
- Price$1.42 as of 2026-08-21 close
- Market cap$142M as of 2026-08-21
- 1-year return-50.0% 2025-08-21 close $2.84 → 2026-08-21 close $1.42
- P/En/a negative earnings
- Net margin-69.5% as of 2026-08-24
- Gross margin+53.9% as of 2026-08-24
- ROE-153.2% as of 2026-08-24
- Debt / equity0.00 as of 2026-08-24
- Revenue growth (YoY)+13.4% as of 2026-08-24
- Revenue CAGR (3y)+4.8% SEC XBRL
- Beta1.39 as of 2026-08-24
- Last reported earnings2026-08-11 SEC EDGAR Form 8-K (Item 2.02)
How STXS compares in its sector
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitybottom 25% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How STEREOTAXIS INC looks technically
STEREOTAXIS INC (STXS) is trading 29.8% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 147 trading days ago — a "death cross", a bearish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 16, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 47, neither overbought (above 70) nor oversold (below 30). It made a new 20-day low about 16 trading days ago. It is 60.4% below its highest point of the past year. Trading volume is unusually light — only about 33% of its 30-day average.
Trend
8
| Distance from the 200-day | it is trading 29.8% below its 200-day average, the long-term trend line — a long-term downtrend | -29.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $1.56 | $1.56 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $2.02 | $2.02 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 9 calendar days ago — the swings before that are what the structure reading is measured on | 9 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 1.59. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible downward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 147 trading days ago — a "death cross", a bearish long-term signal | 147 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 16, below the 25 that marks a real trend) | 15.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 47, neither overbought (above 70) nor oversold (below 30) | 47.5 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($1.30 to $1.50) — its "stochastic" reading is 60 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 60.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 13 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $3.59 | $3.59 |
|---|---|---|
| From the 52-week high | it is 60.4% below its 52-week high (its highest price of the past year) | -60.5% |
| Above the 52-week low | it is 14.5% above its 52-week low (its lowest price of the past year) | +14.5% |
| Below the 52-week high | it is 60.4% below its highest point of the past year | 60.5% |
| Since a 20-day breakout | it made a new 20-day low about 16 trading days ago | 16 sessions |
| Since a 55-day breakout | it made a new 55-day low about 16 trading days ago | 16 sessions |
| All-time high | its highest closing price on record is $154.01 (set on 2007-10-29) | $154.01 |
| Given back of the 52-week move | over the past year its closes ranged ($1.26 to $3.57), and it has recovered only a small part of its fall from last year’s high — 7% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $2.69 to $2.76. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 6.9% |
| From the all-time high | it is 99.1% below its all-time high | -99.1% |
| Nearest price level | it is trading 23.2% below a resistance level at $1.75 — a price it turned at twice since 2026-03-19, most recently on 2026-04-29. Since 2024-08-21 it has 0 such levels below the current price and 10 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +23.2% |
| All-time low | its lowest closing price on record is $0.47 (set on 2016-11-15) | $0.47 |
| Above the all-time low | it is 202.1% above its all-time low | +202.1% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 36th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.0904 between its high and its low — about 6.4% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.0904 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $1.27 and $1.48 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $1.27 – $1.37 – $1.48 |
| Typical daily range (% of price) | its price moves about 6.4% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 6.4% |
| Stretch from the 200-day average | it is trading 6.7 daily ranges below its 200-day average price (29.8% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 6.7 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is unusually light — only about 33% of its 30-day average | 0.33× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a bullish engulfing | 1 session ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 1 session ago |
|---|---|---|
| Since a bearish engulfing | 7 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 7 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 1.4% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +1.4% |
|---|---|---|
| Open gap | it gapped 2.4% above the previous close 14 sessions ago and has not traded back through the level it left behind at 1.26 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.4% |
| Gap filled | a 2.2% gap up opened on 2026-08-19 has been "filled" 1 session ago — price traded back through the level the gap left behind, and it took 1 session to close | 1 session ago |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 5.7 percentage points (the stock lost 3.4% while the market gained 2.3%) | -5.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 28.4 percentage points (the stock lost 25.3% while the market gained 3.1%) | -28.4% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 42.5 percentage points (the stock lost 31.4% while the market gained 11.1%) | -42.5% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 70.5 percentage points (the stock lost 50.0% while the market gained 20.5%) | -70.5% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: MACD momentum is positive — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 17% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 4.9% of the share price. | -17.0% |
|---|
Volume-weighted price
1
| Vs this year’s average price paid | the price is 23% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $1.84 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | -22.9% |
|---|
Price levels it has turned at before
STXS last closed at $1.42 on 2026-08-21. Since 2024-08-21 it has turned at 0 prices below its last close and 10 above; the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $1.75 | Resistance | 23.2% above the last close | turned there twice · 2026-03-19 to 2026-04-29 |
| $1.86 | Resistance | 30.9% above the last close | turned there five times · 2024-10-15 to 2026-07-17 |
| $1.96 | Resistance | 38.0% above the last close | turned there five times · 2025-05-23 to 2026-07-07 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $1.59.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $1.45 and $1.59 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close below $1.30.
This reading has stood for 3 trading days, since 2026-08-19.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · trendless / choppy (low ADX) · lagging the market · Most volatile (6%+ typical daily range) · Stretched far below its 200-day average (6+ daily ranges) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low · volume and relative volume
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.50 mean, 1=Strong Buy…5=Strong Sell) — 4 analysts
- Mean price target$4.13 range $3.50 – $5.00; median $4.00
Analyst estimates, as of 2026-08-24. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for STXS
- Consensus EPS estimate-$0.04667 next reporting period, as of 2026-08-24
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["The company has not achieved profitability, with a net margin of -69.5% as of July 2026, and may struggle to generate sufficient cash from operations to fund ongoing business activities and product development.","Hospital decision-makers may view Stereotaxis systems as too expensive relative to competing alternatives, and long, variable sales cycles create substantial quarterly revenue volatility that makes financial forecasting difficult.","Reliance on contract manufacturers and, in some cases, single suppliers for key components (particularly overseas sourcing of magnet materials) creates supply chain vulnerability and potential manufacturing delays that could harm revenue and competitiveness."]
Insider activity (SEC Form 4)
No open-market insider purchases or sales are on record for STXS — recent Form 4 activity was compensation-related (awards, option exercises, or tax withholding), not open-market buying or selling.
View full insider trading history → View SEC Form 3/4/5 filingsOnly open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding STXS as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 5,339,071
- Reported value $9,823,890
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 1 increased, 4 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
STXS had 4,482,351 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
STXS had 4.47% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.47 days to cover at the same settlement.
- Reported short interest (shares) 4,482,351
- Short interest (% of shares outstanding) 4.47%
- Prior settlement (shares) 4,458,474
- Reported change 0.54%
- Days to cover (reported) 2.47
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Abbott (ABT)
- Boston Scientific (BSX)
- Medtronic (MDT)
- Siemens Healthineers (SIEM)
- Koninklijke Philips (PHG)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare STXS vs…
Frequently asked questions
What does STEREOTAXIS INC (STXS) do?
Stereotaxis designs, manufactures, and markets robotic magnetic navigation systems that enable physicians to perform minimally invasive interventional procedures with greater precision and efficiency. The company's primary product is the Niobe robotic magnetic navigation system, which guides catheters and medical devices through the body using computer-controlled magnetic fields.
What sector is STEREOTAXIS INC (STXS) in?
STEREOTAXIS INC (STXS) is classified in the Health Care sector. Its industry is Robotic-assisted interventional medical devices. It trades on NYSE American.
Who are STEREOTAXIS INC's (STXS) competitors?
Notable peers of STEREOTAXIS INC (STXS) include Abbott, Boston Scientific, Medtronic, Siemens Healthineers and Koninklijke Philips. This peer set is informational only — not financial advice.
Is STEREOTAXIS INC (STXS) overbought or oversold right now?
STEREOTAXIS INC (STXS) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 47, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on STXS come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.